NOS3 and heart failure: Metformin has also improved heart failure and survival in animals via activation of the AMPK pathway and its downstream mediators, endothelial nitric oxide synthase (eNOS) and peroxisome proliferator-activated receptor-gamma coactivator 1 (PGC-1).